Compo-Q: New small molecules for the treatment of prion and neurodegenerative diseases(e.g. Alzheimer’s disease)
Scientists at the University of Duesseldorf and the University of Erlangen have developed new small molecules which can be used for the treatment of diseases characterized by the presence of misfolded
proteins. Examples for such medical conditions are prion diseases, e.g. CJD, as well as neurodegenerative (e.g. Alzheimer’s disease) or neuropsychiatric diseases. Compo-Q have a structural relationship to quinacrine which is considered to be one of the most promising candidate for the clinical therapy of prion diseases. In Compo-Q the “modified quinacrine” is covalently linked to a derivative of another substance which has been proven effective against prion diseases in vitro.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 0
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
New theory reveals the shape of a single photon
A new theory, that explains how light and matter interact at the quantum level has enabled researchers to define for the first time the precise shape of a single photon….
Perovskite research boosts solar cell efficiency and product life
An international team led by the University of Surrey with Imperial College London have identified a strategy to improve both the performance and stability for solar cells made out of…
Neuroscientists discover how the brain slows anxious breathing
Salk scientists identify brain circuit used to consciously slow breathing and confirm this reduces anxiety and negative emotions. Deep breath in, slow breath out… Isn’t it odd that we can…